Print Page
2812
Safety Challenges with Allergen Immunotherapy
Saturday, March 1, 2014: 4:45 PM-6:00 PM
Convention Center, Mezzanine Level, Room 14AB
1.25 CME/ 1.50 CE
Moderator:
Matthew A. Rank , MD FAAAAI
Learning Objectives:
  1. Discuss safety experience with Allergen Immunotherapy given to patients with a history of cancer, HIV positivity, hypertension and other underlying medical conditions
  2. Comment on problems that might arise theoretically and problems that have been reported with AIT in patients taking certain medications (beta-blockers, ACE inhibitors, immunosuppressive drugs, etc)
  3. Recognize factors in an allergy clinic associated with a higher rate of adverse events with AIT and recommend actions in their clinics that might augment safety of AIT
4:45 PM
Allergen Immunotherapy in Patients with Other Special Medical Conditions
Désirée E.S. Larenas Linnemann, MD FAAAAI
Handouts
  • Poster AAAAI 2013 DLarenas.pdf (760.7 kB)
  • EAACI 2013 poster IT and Cancer DLarenas.pdf (504.2 kB)
  • Rank AAAAI poster 2013b.pdf (3.2 MB)
  • 14Jun13 VIT_and_use_in_specific_chronic_medical_conditions.pdf (472.8 kB)
  • 14Jun13 VIT_and_use_in_specific_chronic_medical_conditions.pdf (472.8 kB)
    • 5:00 PM
    Immunotherapy and Medication: Lessons Learned from Experience on How to Approach these Patients
    Christopher W. Calabria, MD
    5:15 PM
    Which Factors Might Enhance Safety of Immunotherapy in Your Clinic?
    David I. Bernstein, MD FAAAAI
    Handouts
  • Allergen Immunotherapy risk aaaai 14.pdf (793.2 kB)
    • 5:30 PM
    Question & Answer
    See more of: Q & A Workshop
    << Previous Session | Next Session >>